GT Biopharma(GTBP)
SAN FRANCISCO, CAPharmaceutical
Focus: GT Biopharma is a public-stage biotech company founded in 1999 focused on antioxidant therapeutics and antibodies for metabolic diseases and oncology. The company operates a diversified pipeline spanning surgical interventions, immunotherapies, and radiation-based oncology treatments.
Profile data last refreshed 23h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About GT Biopharma
AI assessmentNot HiringNo open roles listed right now. Follow GT Biopharma to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from GT Biopharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Help build intelligence for GT Biopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.